EcoDrugPlus

Dopamine Receptor D5

Ensembl ID : ENSCPOG00000007877
Gene Symbol: DRD5
2 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSCPOG00000015234
Gene Symbol: ENPP2
2 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSCPOG00000003464
Gene Symbol: EGLN2
2 Cross references
194 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSCPOG00000013369
Gene Symbol: EGLN3
4 Cross references
208 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSCPOG00000026112
Gene Symbol: ELANE
2 Cross references
91 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSCPOG00000014242
Gene Symbol: EPAS1
2 Cross references
225 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSCPOG00000011666
Gene Symbol: ECE1
4 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSCPOG00000004559
Gene Symbol: EDNRA
2 Cross references
269 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSCPOG00000015463
Gene Symbol: EDNRB
2 Cross references
267 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSCPOG00000003710
Gene Symbol: EZH2
4 Cross references
236 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSCPOG00000000040
Gene Symbol: EGFR
2 Cross references
286 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSCPOG00000037609
Gene Symbol: EPHX2
2 Cross references
204 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).